ENTPD1 and head and neck squamous cell carcinoma: As shown in Figures 5A,B, the frequency of CD4+CD25+CD39+Foxp3+Treg significantly increased in these HNSCC patients after induction phase (3 months) as compared to baseline Treg levels.